BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35764701)

  • 1. Combination therapy of doxorubicin and Sildenafil inhibits the growth of pediatric rhabdomyosarcoma.
    Urla C; Stagno MJ; Fuchs J; Warmann SW; Schmid E
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2513-2522. PubMed ID: 35764701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D,L-Methadone enhances the cytotoxic activity of standard chemotherapeutic agents on pediatric rhabdomyosarcoma.
    Urla C; Corteletti I; Raible AS; Handgretinger R; Fuchs J; Warmann SW; Schmid E
    J Cancer Res Clin Oncol; 2022 Jun; 148(6):1337-1350. PubMed ID: 35182225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-type natriuretic peptide in combination with sildenafil attenuates proliferation of rhabdomyosarcoma cells.
    Zenitani M; Nojiri T; Uehara S; Miura K; Hosoda H; Kimura T; Nakahata K; Miyazato M; Okuyama H; Kangawa K
    Cancer Med; 2016 May; 5(5):795-805. PubMed ID: 26816265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and Glucocorticoid Inducible Kinase 1-Sensitive Survival, Proliferation and Migration of Rhabdomyosarcoma Cells.
    Schmid E; Stagno MJ; Yan J; Schleicher S; Yu W; Honisch S; Lang F; Fuchs J; Seitz G
    Cell Physiol Biochem; 2017; 43(3):1301-1308. PubMed ID: 28992614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sildenafil enhances cisplatin-induced apoptosis in human breast adenocarcinoma cells.
    Hassanvand F; Mohammadi T; Ayoubzadeh N; Tavakoli A; Hassanzadeh N; Sanikhani NS; Azimi AI; Mirzaei HR; Khodamoradi M; Goudarzi KA; Pourghadamyari H; Zaimy MA
    J Cancer Res Ther; 2020; 16(6):1412-1418. PubMed ID: 33342806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects of curcumin in pediatric rhabdomyosarcoma in combination with chemotherapy and phototherapy in vitro.
    Sorg C; Schmid E; Bortel N; Fuchs J; Ellerkamp V
    Int J Oncol; 2021 Feb; 58(2):266-274. PubMed ID: 33491749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MI-63: a novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53.
    Canner JA; Sobo M; Ball S; Hutzen B; DeAngelis S; Willis W; Studebaker AW; Ding K; Wang S; Yang D; Lin J
    Br J Cancer; 2009 Sep; 101(5):774-81. PubMed ID: 19707204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic drugs in combination with the CXCR4 antagonist AMD3100 as a potential treatment option for pediatric rhabdomyosarcoma.
    Regenbogen S; Stagno MJ; Schleicher S; Schilbach K; Bösmüller H; Fuchs J; Schmid E; Seitz G
    Int J Oncol; 2020 Jul; 57(1):289-300. PubMed ID: 32377699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo.
    Xu N; Hua Z; Ba G; Zhang S; Liu Z; Thiele CJ; Li Z
    J Exp Clin Cancer Res; 2019 Mar; 38(1):118. PubMed ID: 30850026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance.
    Marampon F; Codenotti S; Megiorni F; Del Fattore A; Camero S; Gravina GL; Festuccia C; Musio D; De Felice F; Nardone V; Santoro AN; Dominici C; Fanzani A; Pirtoli L; Fioravanti A; Tombolini V; Cheleschi S; Tini P
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):881-893. PubMed ID: 30701326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Store-operated Ca(2+) entry in rhabdomyosarcoma cells.
    Schmid E; Stagno MJ; Yan J; Stournaras C; Lang F; Fuchs J; Seitz G
    Biochem Biophys Res Commun; 2016 Aug; 477(1):129-136. PubMed ID: 27291153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibition.
    Megiorni F; McDowell HP; Camero S; Mannarino O; Ceccarelli S; Paiano M; Losty PD; Pizer B; Shukla R; Pizzuti A; Clerico A; Dominici C
    J Exp Clin Cancer Res; 2015 Oct; 34():112. PubMed ID: 26445453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of phosphodiesterase 5 by sildenafil reduces tumor growth and potentiates tumor-killing ability of cisplatin in vivo against T cell lymphoma: Implication of modulated apoptosis, reactive oxygen species homeostasis, glucose metabolism, and pH regulation.
    Rawat SG; Tiwari RK; Kumar A
    Environ Toxicol; 2024 Apr; 39(4):1909-1922. PubMed ID: 38059649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin Gallate Inhibits Cell Growth and Hedgehog Signalling in Human Rhabdomyosarcoma Cell Lines.
    Mayer BFB; Stagno MJ; Fuchs J; Warmann SW; Schmid E
    Anticancer Res; 2023 Mar; 43(3):1025-1030. PubMed ID: 36854509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase 5 inhibitor sildenafil potentiates the antitumor activity of cisplatin by ROS-mediated apoptosis: a role of deregulated glucose metabolism.
    Rawat SG; Tiwari RK; Jaiswara PK; Gupta VK; Sonker P; Vishvakarma NK; Kumar S; Pathak C; Gautam V; Kumar A
    Apoptosis; 2022 Aug; 27(7-8):606-618. PubMed ID: 35725975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemosensitization of rhabdomyosarcoma cells by the histone deacetylase inhibitor SAHA.
    Heinicke U; Fulda S
    Cancer Lett; 2014 Aug; 351(1):50-8. PubMed ID: 24814395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of PDE5 in Oral Squamous Cell Carcinoma - Effect of Sildenafil Citrate.
    Iwasaki T; Onda T; Honda H; Hayashi K; Shibahara T; Nomura T; Takano M
    Anticancer Res; 2021 May; 41(5):2297-2306. PubMed ID: 33952455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JNJ-26481585 primes rhabdomyosarcoma cells for chemotherapeutics by engaging the mitochondrial pathway of apoptosis.
    Heinicke U; Kupka J; Fulda S
    Oncotarget; 2015 Nov; 6(35):37836-51. PubMed ID: 26473375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines.
    Codenotti S; Poli M; Asperti M; Zizioli D; Marampon F; Fanzani A
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1717-1730. PubMed ID: 29971532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin selective inhibitor YM155 promotes cisplatin‑induced apoptosis in embryonal rhabdomyosarcoma.
    Ueno T; Uehara S; Nakahata K; Okuyama H
    Int J Oncol; 2016 May; 48(5):1847-54. PubMed ID: 26983495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.